We use cookies to measure traffic and show relevant ads. By clicking Accept you agree to our use of analytics and advertising cookies.
NEJM报道了小鼠发作性睡病的基因疗法，但武田已准备推出oveporexone。分析为什么药片比脑内注射更胜一筹。阅读详情。
